Sareum Holdings plc announced that based on the dynamic business performance in the first half, strong order intake, and on expanded production capacities, management raised its full-year growth forecast again at the beginning of July for fiscal 2021. Accordingly, the Sartorius Group projects consolidated sales growth of around 45%(previously around 35%). For the Bioprocess Solutions Division, sales are anticipated to increase by about 50% (previously about 40%). Sales growth for the Lab Products & Services Division is expected to be around 30% (previously around 20%).